|
|
 |
Publications
2004 Articles
Barton JJS, Cherkasova MV, Hefter R, Cox T, O’Connor MG, Manoach DS.
Are patients with social developmental disorders prosopagnosic? Perceptual heterogeneity in the Asperger and socio-emotional processing disorders. Brain 2004; 127:1706-1716. View Abstract
Casey DE, Haupt DW, Newcomer JW, Henderson DC, Sernyak MJ, Davidson M, Lindenmayer JP, Manoukian SV, Banerji MA, Lebovitz HE, Hennekens CH. Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia. Journal of Clinical Psychiatry. 2004; 65 (Suppl 7):4-18. View Abstract
Cather C, Penn D, Otto MW, Goff DC. Advances in the cognitive-behavioral treatment of schizophrenia: a focus on delusions. Journal of Cognitive Psychotherapy: An International Quarterly 2004; 18:207-221.
Evins AE, Cather C, Rigotti NA, Freudenreich O, Henderson DC, Olm-Shipman C, Goff DC. Two-year follow up of a smoking cessation trial in patients with schizophrenia: increased rates of smoking cessation and reduction. Journal of Clinical Psychiatry 2004; 65:307-311. View Abstract
Freudenreich O, Beebe M, Goff DC. Clozapine-induced sialorrhea treated with sublingual ipratropium spray: a case series [letter]. Journal of Clinical Psychopharmacology 2004; 24:98-100. View Abstract
Freudenreich O, Cather C, Evins AE, Henderson DC, Goff DC. Attitudes of schizophrenia outpatients towards psychiatric medications: relationship to clinical variables and insight. Journal of Clinical Psychiatry 2004; 65:1372-6. View Abstract
Freudenreich O, Deckersbach T, Goff DC. Insight into current symptoms of schizophrenia. Association with frontal cortical function and affect. Acta Psychiatrica Scandinavica 2004; 110: 14-20. View Abstract
Goff DC, Bottiglieri T, Arning E, Shih V, Freudenreich O, Evins AE, Henderson DC, Baer L, Coyle J. Folate, homocysteine, and negative symptoms in schizophrenia. American Journal of Psychiatry 2004; 161:1705-1708. View Abstract
Goff DC, Freudenreich O. Focus on polypharmacy in schzophrenia: Does anyone truly benefit? International Journal of Neuropsychopharmacology 2004; 7:109-111.
Goff DC, Herz L, Posever T, Shih V, Tsai G, Henderson DC, Freudenreich O, Evins AE, Yovel I, Zhang H, Schoenfeld D. A six-month, placebo-controlled trial of D-cycloserine co-treatment with conventional antipsychotics in schizophrenia patients. Psychopharmacology. (Berl) October 2004 (on line). View Abstract
Heckers S, Weiss AP, Deckersbach T, Goff D, Morecraft RJ, Bush G. Anterior cingulate cortex activation during cognitive interference in schizophrenia. American Journal of Psychiatry 2004; 161:707-715. View Abstract
Henderson DC, Daley TB, Kunkel L, Rodrigues-Scott M, Koul P, Hayden D. Clozapine and hypertension. Journal of Clinical Psychiatry 2004; 65: 686-689. View Abstract
Long C, Brown EN, Manoach DS, Solo V. Spatiotemporal Wavelet Analysis for functional MRI. Neuroimage. 2004; 23:500-516. View Abstract
Manoach DS, Cain MS, Vangel MG, Khurana A, Goff DC. Stickgold R. A failure of sleep-dependent procedural learning in chronic, medicated schizophrenia. Biological Psychiatry. 2004; 56: 951-956. View Abstract
Manoach DS, Lindgren KA, Barton JJS: Deficient saccadic inhibition in Asperger’s Disorder and the
Social-Emotional Processing Disorder. Journal of Neurology, Neurosurgery & Psychiatry, 75(12): 1719-1726, 2004. View Abstract
Manoach DS, White N, Lindgren KA, Heckers S, Coleman MJ, Dubal S, Holzman PS Hemispheric specialization of the lateral prefrontal cortex for strategic processing during spatial and shape working memory. Neuroimage, 21(3): 894-904, 2004. View Abstract
Niznikiewicz M, Friedman M, Shenton M, Volgmaier M, Nestor P, Frumin M, Seidman L, Sutton J, McCarley R. Processing sentence context in women with schizotypal personality disorder: an ERP study. Psychophysiology. 2004;41: 367-371. View Abstract
O’Donnell WJ, Kradin RL, Evins AE, Wittram C. A 52-year-old woman with recurrent bouts of atypical pneumonias. Case Records of the Massachusetts General Hospital. New England Journal of Medicine, 2004; 351 (26): 2741-2749. View Abstract
Penn DL, Mueser KT, Tarrier N, Gloege A, Cather C, Serrano D, Otto MW. Supportive therapy for schizophrenia: Possible mechanisms and implications for adjunctive psychosocial treatments for schizophrenia. Schizophrenia Bulletin 2004; 30:101-112. View Abstract
Ramchandran RS, Manoach DS, Cherkasova MV, Lindgren KA, Goff DC, Barton JJS. The relation of saccadic peak velocity to latency: evidence for a new prosaccadic abnormality in schizophrenia. Experimental Brain Research 2004; 29. View Abstract
Roberts DL, Penn DL, Cather C, Otto MW, Goff DC. Should CBT target the social impairments associated with schizophrenia? Journal of Cognitive Psychotherapy. An International Quarterly. 2004; 18:255-264.
Weiss AP, Goff D, DeWitt I, Zalesak M, Kunkel L, Heckers S. Impaired hippocampal function during the detection of novel words in schizophrenia. Biological Psychiatry 2004; 55:668-675. View Abstract
Top of Page
| |
